...
search icon
aura-img

Aura Biosciences Inc, Common Stock

AURA

NMQ

$6.63

-$0.34

(-4.88%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$392.49M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
283.99K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.42
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.34 L
$12.38 H
$6.63

About Aura Biosciences Inc, Common Stock

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer, as an alternative to bacillus calmette"guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameAURASectorS&P500
1-Week Return7.98%1.85%1.23%
1-Month Return23.93%-0.15%3.45%
3-Month Return-10.04%-7.06%8.43%
6-Month Return-23.44%-4.5%-0.74%
1-Year Return-7.14%-7.25%12.33%
3-Year Return-49.96%11.55%60.94%
5-Year Return-55.2%39.99%100.63%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue831.00K835.00K1.18M1.29M1.22M[{"date":"2020-12-31","value":64.17,"profit":true},{"date":"2021-12-31","value":64.48,"profit":true},{"date":"2022-12-31","value":90.89,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":94.44,"profit":true}]
Gross Profit(831.00K)(835.00K)(1.18M)(1.29M)-[{"date":"2020-12-31","value":-83100000,"profit":false},{"date":"2021-12-31","value":-83500000,"profit":false},{"date":"2022-12-31","value":-117700000,"profit":false},{"date":"2023-12-31","value":-129500000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses22.21M35.25M60.30M84.99M96.12M[{"date":"2020-12-31","value":23.1,"profit":true},{"date":"2021-12-31","value":36.67,"profit":true},{"date":"2022-12-31","value":62.73,"profit":true},{"date":"2023-12-31","value":88.43,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(22.21M)(35.25M)(60.30M)(84.99M)(96.12M)[{"date":"2020-12-31","value":-2220600000,"profit":false},{"date":"2021-12-31","value":-3525000000,"profit":false},{"date":"2022-12-31","value":-6029500000,"profit":false},{"date":"2023-12-31","value":-8499100000,"profit":false},{"date":"2024-12-31","value":-9611600000,"profit":false}]
Total Non-Operating Income/Expense-12.00K3.40M15.76M18.74M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":0.06,"profit":true},{"date":"2022-12-31","value":18.12,"profit":true},{"date":"2023-12-31","value":84.12,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(22.21M)(35.25M)(58.76M)(76.27M)(86.81M)[{"date":"2020-12-31","value":-2220600000,"profit":false},{"date":"2021-12-31","value":-3525100000,"profit":false},{"date":"2022-12-31","value":-5876300000,"profit":false},{"date":"2023-12-31","value":-7627100000,"profit":false},{"date":"2024-12-31","value":-8680700000,"profit":false}]
Income Taxes3.00K(830.00K)(1.53M)137.00K112.00K[{"date":"2020-12-31","value":2.19,"profit":true},{"date":"2021-12-31","value":-605.84,"profit":false},{"date":"2022-12-31","value":-1118.25,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":81.75,"profit":true}]
Income After Taxes(22.21M)(34.42M)(57.23M)(76.41M)(86.92M)[{"date":"2020-12-31","value":-2220900000,"profit":false},{"date":"2021-12-31","value":-3442100000,"profit":false},{"date":"2022-12-31","value":-5723100000,"profit":false},{"date":"2023-12-31","value":-7640800000,"profit":false},{"date":"2024-12-31","value":-8691900000,"profit":false}]
Income From Continuous Operations(22.21M)(35.25M)(58.76M)(70.84M)(86.92M)[{"date":"2020-12-31","value":-2220600000,"profit":false},{"date":"2021-12-31","value":-3525100000,"profit":false},{"date":"2022-12-31","value":-5876300000,"profit":false},{"date":"2023-12-31","value":-7083600000,"profit":false},{"date":"2024-12-31","value":-8691900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(22.21M)(34.42M)(57.23M)(76.41M)(86.92M)[{"date":"2020-12-31","value":-2220900000,"profit":false},{"date":"2021-12-31","value":-3442100000,"profit":false},{"date":"2022-12-31","value":-5723100000,"profit":false},{"date":"2023-12-31","value":-7640800000,"profit":false},{"date":"2024-12-31","value":-8691900000,"profit":false}]
EPS (Diluted)(76.04)(31.28)(1.99)(1.98)(1.75)[{"date":"2020-12-31","value":-7604.19,"profit":false},{"date":"2021-12-31","value":-3127.69,"profit":false},{"date":"2022-12-31","value":-199,"profit":false},{"date":"2023-12-31","value":-198,"profit":false},{"date":"2024-12-31","value":-175,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

AURA
Cash Ratio 10.52
Current Ratio 11.06

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AURA
ROA (LTM) -32.92%
ROE (LTM) -56.24%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AURA
Debt Ratio Lower is generally better. Negative is bad. 0.18
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.82

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AURA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 3.05
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Aura Biosciences Inc share price today?

Aura Biosciences Inc (AURA) share price today is $6.63

Can Indians buy Aura Biosciences Inc shares?

Yes, Indians can buy shares of Aura Biosciences Inc (AURA) on Vested. To buy Aura Biosciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AURA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Aura Biosciences Inc be purchased?

Yes, you can purchase fractional shares of Aura Biosciences Inc (AURA) via the Vested app. You can start investing in Aura Biosciences Inc (AURA) with a minimum investment of $1.

How to invest in Aura Biosciences Inc shares from India?

You can invest in shares of Aura Biosciences Inc (AURA) via Vested in three simple steps:

  • Click on Sign Up or Invest in AURA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Aura Biosciences Inc shares
What is Aura Biosciences Inc 52-week high and low stock price?

The 52-week high price of Aura Biosciences Inc (AURA) is $12.38. The 52-week low price of Aura Biosciences Inc (AURA) is $4.34.

What is Aura Biosciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Aura Biosciences Inc (AURA) is 3.05

What is the Market Cap of Aura Biosciences Inc?

The market capitalization of Aura Biosciences Inc (AURA) is $392.49M

What is Aura Biosciences Inc’s stock symbol?

The stock symbol (or ticker) of Aura Biosciences Inc is AURA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top